Maleka Najmi

Maleka Najmi

Auto-generated profile, based on publicly available information

Maleka Najmi

Department of Internal Medicine, Baylor Scott & White Medical Center, Temple, USA

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 April 2021 in Archives of Dermatological Research
Verified
Journal Article
Closed access
PDF file
MNMaleka Najmi
Maleka Najmi
ABAshley E. Brown
Ashley E. Brown
SHSarah R. Harrington
Sarah R. Harrington
DFDavid Farris
David Farris
SSSarah Sepulveda
Sarah Sepulveda
KNKelly C. Nelson
Kelly C. Nelson

16 June 2022 in Journal of General Internal Medicine
Verified
Journal Article
Closed access
PDF file
ABAshley E. Brown
Ashley E. Brown
MNMaleka Najmi
Maleka Najmi
TDTaylor Duke
Taylor Duke
DGDaniel A. Grabell
Daniel A. Grabell
MKMisha V. Koshelev
Misha V. Koshelev
KNKelly C. Nelson
Kelly C. Nelson

25 September 2022 in Dermatology and Therapy
Verified
Journal Article
Open access
PDF file
MNMaleka Najmi
Maleka Najmi
TTTiffaney Tran
Tiffaney Tran
RWRussell G. Witt
Russell G. Witt
KNKelly C. Nelson
Kelly C. Nelson
For patients with metastatic melanoma, immunotherapy agents represent a promising treatment option, and researchers are actively seeking to identify factors that may predict a favorable response in patients. Recent studies have elucidated possible associations between the gut microbiome and the effects of immunotherapy, where variations in the gut microbiome may influence treatment response and frequency of adverse effects. In this clinical review, we describe the current literature related to the gut microbiome in the setting of immunotherapy, and we provide an overview of interventions under investigation that may modulate the gut microbiome. These interventions include fecal microbiota transplantation, probiotics, and dietary modifications.

1 February 2020 in JAAD Case Reports
Verified
Journal Article
Open access
MNMaleka Najmi
Maleka Najmi
LSLeigha Sharp
Leigha Sharp
RKRamya Kollipara
Ramya Kollipara
MTMichelle Tarbox
Michelle Tarbox

17 September 2020 in Baylor University Medical Center Proceedings
Verified
Journal Article
Open access
MNMaleka Najmi
Maleka Najmi
LSLeigha Sharp
Leigha Sharp
MTMichelle Tarbox
Michelle Tarbox
CSCloyce Stetson
Cloyce Stetson
We describe a 69-year-old white man with a recent history of a left forearm sarcoma resection treated with a split-thickness skin graft and radiotherapy who presented with cellulitis of the left forearm, for which a 2-week course of trimethoprim-sulfamethoxazole was prescribed. Ten days into treatment, he presented with flu-like symptoms and a rash. He was eventually diagnosed with Stevens-Johnson syndrome accentuated on the donor split-thickness skin graft on the left thigh region mimicking a recall reaction. There are no other reported cases of Stevens-Johnson syndrome localized within donor graft sites; therefore, this case may represent a novel form of recall reaction.

1 December 2021 in Journal of the American Academy of Dermatology
Verified
Journal Article
Closed access
MNMaleka Najmi
Maleka Najmi
TSTorunn E. Sivesind
Torunn E. Sivesind
JTJason Thomson
Jason Thomson
SHSarah Hogan
Sarah Hogan
RDRobert P. Dellavalle
Robert P. Dellavalle